Zynerba Pharma (ZYNE) Reports Q4 Loss of $0.33/sh

Zynerba Pharma (NASDAQ: ZYNE) reported Q4 EPS of ($0.33), versus ($0.46) reported last year.

For earnings history and earnings-related data on Zynerba Pharma (ZYNE) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Home Depot beats estimates, reaffirms fiscal 2026 guidance